Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this project, the investigators hope to evaluate effective methods of communication with patients with multiple sclerosis regarding habits of physical activity, sleep, and diet. Currently, there is weak evidence regarding how to deliver adequate information at scale in the clinics with respect to diet, exercise, and sleep. It is unclear if receiving structured information impacts patient-reported outcomes in multiple sclerosis (MS).
The study team hopes to evaluate the efficacy of after visit direct patient messaging in promoting any behavioral changes, the sustainability of those behavioral changes, and most importantly, if those changes impact patient-reported sense of self-efficacy in the participants disease management. In addition, the study team hopes that the data collected during this study will provide answers on how providing wellness strategies impacts patient reported outcomes, markers of behavior, and sense of disease progression.
This will be a prospective randomized control trial assessing the impact of the delivery of wellness-related information on patient-reported outcomes in multiple sclerosis. The investigators plan to query all patients who meet inclusion criteria over the course of at least three consecutive months who will be seen at the Johns Hopkins Outpatient Center Multiple Sclerosis clinic. On average, 200 patients are seen in the MS clinic monthly, and the investigators hope to enroll 120 patients in this time period. If the investigators are unable to reach this target number in two months, the investigators will continue to message patients over consecutive months until the investigators reach this number. The study team will send a recruitment message through MyChart to all eligible patients prior to the patients next clinic appointment to participate in the study, after which the patients will be consented (with documentation of waiver of consent) if interested. Those who are interested will be asked to fill out a series of electronic baseline questionnaires prior to the patient's appointment (sent by REDCap using subject-specific links).
Participants will subsequently be randomized 1:1 (stratified within each provider's daily clinic schedule) to either receive a secure message providing a set script (see Supplementary Materials) containing information on a number of wellness-related topics in MS (sleep, diet, exercise), or to receiving no additional information other than that provided by the participants clinician. This message will be sent as a secure message through Epic by a member of the study team by the end of the clinic day.
At one month and three months after the clinic visit, the study team will send the same questionnaires as were sent at baseline, assessing self-efficacy, reported physical activity, dietary habits, and sleep quality through REDCap subject-specific links.
The investigators will assess for any differences in outcomes between the control group and the group who received the wellness-related secure message. The investigators will evaluate for covariates that were imbalanced and adjust models when imbalance did occur, which is plausible given the expected sample size. In addition, the investigators will also evaluate via chart review whether diet, exercise, and sleep were assessed or discussed during the clinic visit.
In addition, the investigators will use descriptive statistics to describe participants and compare those who agree versus those who do not agree to participate. The investigators hope to evaluate density of use of the electronic medical record amongst this cohort, as well as demographic data on social determinants of health, including race, socioeconomic status, and geographic location, in order to evaluate predictors of responsiveness to the messaging.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Wellness Smartphrase | Experimental | This arm will receive a secure message after the conclusion of their standard clinic visit providing a set script containing information on a number of wellness-related topics in MS (sleep, diet, exercise). |
|
| No Intervention | No Intervention | This arm will not receive a secure message after their appointment, and will instead receive their standard care with their provider. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Wellness Patient Message | Behavioral | The intervention is a detailed patient message containing information on strategies for exercise in MS, how to maintain proper sleep, and dietary improvements to maximize health. These strategies are derived from information provided by the National MS Society in their website and covers these topics in greater detail than would normally be addressed in a normal clinic visit. The message also directs patients to the National MS Society website if they would like more information. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in self-efficacy as assessed by the MS Self-Efficacy Scale (MSSE) | Patients will take the MS Self-Efficacy Scale (MSSE), which has a score range 90-900, with higher scores reflecting greater sense of self-efficacy | Baseline, 1 month, 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Sleep Disturbance the Neuro-Quality of Life Sleep disturbance short form | Patient-reported outcomes on the Neuro-Quality of Life Sleep disturbance short form, which has a score range of 8-40, with higher scores reflecting better quality of sleep. | Baseline, 1 month, 3 months |
| Change in Diet behavior Scores as assessed by the Mediterranean-DASH Intervention for Neurodegenerative Delay score (MIND Diet score) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Shuvro Roy, MD | Johns Hopkins University | Study Director |
| Ellen Mowry, MD | Johns Hopkins University | Principal Investigator |
| Scott Newsome, MD | Johns Hopkins University | Study Director |
| Peter Calabresi, MD | Johns Hopkins University | Study Director |
| Shiv Saidha, MBBCh | Johns Hopkins University | Study Director |
| Pavan Bhargava, MD | Johns Hopkins University | Study Director |
| Michael Kornberg, MD | Johns Hopkins University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Johns Hopkins Outpatient Center | Baltimore | Maryland | 21287 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28080254 | Background | Motl RW, Mowry EM, Ehde DM, LaRocca NG, Smith KE, Costello K, Shinto L, Ng AV, Sullivan AB, Giesser B, McCully KK, Fernhall B, Bishop M, Plow M, Casaccia P, Chiaravalloti ND. Wellness and multiple sclerosis: The National MS Society establishes a Wellness Research Working Group and research priorities. Mult Scler. 2018 Mar;24(3):262-267. doi: 10.1177/1352458516687404. Epub 2017 Jan 12. | |
| 19085318 |
Not provided
Not provided
There is no plan to share individual participant data
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
Not provided
Not provided
Patients will be randomized 1:1 within provider schedules to either receive a secure message containing a set script on wellness-related topics in MS, or no additional information other than that provided by their clinician.
Not provided
Not provided
Participants will not know which arm they are assigned to, and neither will their provider.
|
Patient-reported behaviors on diet through the Mediterranean-DASH Intervention for Neurodegenerative Delay score (MIND Diet score), which has a score range of 0-15, with higher scores reflecting a higher, healthier, quality of diet. |
| Baseline, 1 month, 3 months |
| Change in Reported physical activity as assessed by the Godin Leisure-Time Exercise Questionnaire (GLTEQ) | Patient-reported behaviors on physical activity through the Godin Leisure-Time Exercise Questionnaire (GLTEQ). The score range is from 0-119, with higher scores reflecting a greater degree of physical exercise. | Baseline, 1 month, 3 month |
| Change in Reported physical activity as assessed by the International Physical Activity Questionnaire (IPAQ) short form | Patient-reported behaviors on physical activity through the International Physical Activity Questionnaire (IPAQ) short form. Results are reported in metabolic minutes (MET-min), and are continuous, with range of 0-200,000 per week, and higher scores indicating greater physical activity. | Baseline, 1 month, 3 month |
| Background |
| Motl RW, McAuley E, Snook EM, Gliottoni RC. Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support. Psychol Health Med. 2009 Jan;14(1):111-24. doi: 10.1080/13548500802241902. |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |